PURIFICATION OF PERTUSSIS HAEMAGGLUTININS

The Leukocytosis Promoting Factor (LPF) of Bordetella haemagglutinin(HG) is separated from crude cell supernatant or partially purified protein by affinity chromatography on a column material consisting of an insoluble polymeric support to which is bound a sialoprotein (glycoprotein containing siali...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: IRONS, LAURENCE I, MACLENNAN, ALASTAIR P
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator IRONS, LAURENCE I
MACLENNAN, ALASTAIR P
description The Leukocytosis Promoting Factor (LPF) of Bordetella haemagglutinin(HG) is separated from crude cell supernatant or partially purified protein by affinity chromatography on a column material consisting of an insoluble polymeric support to which is bound a sialoprotein (glycoprotein containing sialic acid) or other substance rich in sialic acid. The sialoprotein was preferably a plasma sialoprotein such as haptoglobin or ceruloplasmin or a salivary mucin, and the polymeric support was preferably an agarose gel, though other conventional supports could be used. By this process, on treatment of an ammonium sulphate pre-cipitated extract, the haemagglutinating activity may be increased 300-600 fold over the extract and 10,000 times over the crude centrifuged cell supernatant. Alternatively a fraction substantially free from LPF-HG may be collected. Pertus-sis LPF-HG is reported to have various useful clinical properties, in particular adjuvant effect on antigenicity and the abilities to induce leukocytosis and sensitivity to histamine. By the process of the present invention LPF-HG may be produced cheaply and in large quantities or removed from other cell extracts.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA1114293A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA1114293A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA1114293A3</originalsourceid><addsrcrecordid>eNrjZNAMCA3ydPN0dgzx9PdT8HdTCHANCgkNDvYMVvBwdPV1dHf3CQ3x9PP0C-ZhYE1LzClO5YXS3Azybq4hzh66qQX58anFBYnJqXmpJfHOjoaGhiZGlsaOxoRVAADHuCPQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PURIFICATION OF PERTUSSIS HAEMAGGLUTININS</title><source>esp@cenet</source><creator>IRONS, LAURENCE I ; MACLENNAN, ALASTAIR P</creator><creatorcontrib>IRONS, LAURENCE I ; MACLENNAN, ALASTAIR P</creatorcontrib><description>The Leukocytosis Promoting Factor (LPF) of Bordetella haemagglutinin(HG) is separated from crude cell supernatant or partially purified protein by affinity chromatography on a column material consisting of an insoluble polymeric support to which is bound a sialoprotein (glycoprotein containing sialic acid) or other substance rich in sialic acid. The sialoprotein was preferably a plasma sialoprotein such as haptoglobin or ceruloplasmin or a salivary mucin, and the polymeric support was preferably an agarose gel, though other conventional supports could be used. By this process, on treatment of an ammonium sulphate pre-cipitated extract, the haemagglutinating activity may be increased 300-600 fold over the extract and 10,000 times over the crude centrifuged cell supernatant. Alternatively a fraction substantially free from LPF-HG may be collected. Pertus-sis LPF-HG is reported to have various useful clinical properties, in particular adjuvant effect on antigenicity and the abilities to induce leukocytosis and sensitivity to histamine. By the process of the present invention LPF-HG may be produced cheaply and in large quantities or removed from other cell extracts.</description><language>eng ; fre</language><subject>CHEMISTRY ; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC ; GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; TECHNICAL SUBJECTS COVERED BY FORMER USPC ; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS ; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ARTCOLLECTIONS [XRACs] AND DIGESTS</subject><creationdate>1981</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19811215&amp;DB=EPODOC&amp;CC=CA&amp;NR=1114293A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19811215&amp;DB=EPODOC&amp;CC=CA&amp;NR=1114293A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>IRONS, LAURENCE I</creatorcontrib><creatorcontrib>MACLENNAN, ALASTAIR P</creatorcontrib><title>PURIFICATION OF PERTUSSIS HAEMAGGLUTININS</title><description>The Leukocytosis Promoting Factor (LPF) of Bordetella haemagglutinin(HG) is separated from crude cell supernatant or partially purified protein by affinity chromatography on a column material consisting of an insoluble polymeric support to which is bound a sialoprotein (glycoprotein containing sialic acid) or other substance rich in sialic acid. The sialoprotein was preferably a plasma sialoprotein such as haptoglobin or ceruloplasmin or a salivary mucin, and the polymeric support was preferably an agarose gel, though other conventional supports could be used. By this process, on treatment of an ammonium sulphate pre-cipitated extract, the haemagglutinating activity may be increased 300-600 fold over the extract and 10,000 times over the crude centrifuged cell supernatant. Alternatively a fraction substantially free from LPF-HG may be collected. Pertus-sis LPF-HG is reported to have various useful clinical properties, in particular adjuvant effect on antigenicity and the abilities to induce leukocytosis and sensitivity to histamine. By the process of the present invention LPF-HG may be produced cheaply and in large quantities or removed from other cell extracts.</description><subject>CHEMISTRY</subject><subject>GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC</subject><subject>GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>TECHNICAL SUBJECTS COVERED BY FORMER USPC</subject><subject>TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS</subject><subject>TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ARTCOLLECTIONS [XRACs] AND DIGESTS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1981</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNAMCA3ydPN0dgzx9PdT8HdTCHANCgkNDvYMVvBwdPV1dHf3CQ3x9PP0C-ZhYE1LzClO5YXS3Azybq4hzh66qQX58anFBYnJqXmpJfHOjoaGhiZGlsaOxoRVAADHuCPQ</recordid><startdate>19811215</startdate><enddate>19811215</enddate><creator>IRONS, LAURENCE I</creator><creator>MACLENNAN, ALASTAIR P</creator><scope>EVB</scope></search><sort><creationdate>19811215</creationdate><title>PURIFICATION OF PERTUSSIS HAEMAGGLUTININS</title><author>IRONS, LAURENCE I ; MACLENNAN, ALASTAIR P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA1114293A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>1981</creationdate><topic>CHEMISTRY</topic><topic>GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC</topic><topic>GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>TECHNICAL SUBJECTS COVERED BY FORMER USPC</topic><topic>TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS</topic><topic>TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ARTCOLLECTIONS [XRACs] AND DIGESTS</topic><toplevel>online_resources</toplevel><creatorcontrib>IRONS, LAURENCE I</creatorcontrib><creatorcontrib>MACLENNAN, ALASTAIR P</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>IRONS, LAURENCE I</au><au>MACLENNAN, ALASTAIR P</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PURIFICATION OF PERTUSSIS HAEMAGGLUTININS</title><date>1981-12-15</date><risdate>1981</risdate><abstract>The Leukocytosis Promoting Factor (LPF) of Bordetella haemagglutinin(HG) is separated from crude cell supernatant or partially purified protein by affinity chromatography on a column material consisting of an insoluble polymeric support to which is bound a sialoprotein (glycoprotein containing sialic acid) or other substance rich in sialic acid. The sialoprotein was preferably a plasma sialoprotein such as haptoglobin or ceruloplasmin or a salivary mucin, and the polymeric support was preferably an agarose gel, though other conventional supports could be used. By this process, on treatment of an ammonium sulphate pre-cipitated extract, the haemagglutinating activity may be increased 300-600 fold over the extract and 10,000 times over the crude centrifuged cell supernatant. Alternatively a fraction substantially free from LPF-HG may be collected. Pertus-sis LPF-HG is reported to have various useful clinical properties, in particular adjuvant effect on antigenicity and the abilities to induce leukocytosis and sensitivity to histamine. By the process of the present invention LPF-HG may be produced cheaply and in large quantities or removed from other cell extracts.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_CA1114293A
source esp@cenet
subjects CHEMISTRY
GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
TECHNICAL SUBJECTS COVERED BY FORMER USPC
TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ARTCOLLECTIONS [XRACs] AND DIGESTS
title PURIFICATION OF PERTUSSIS HAEMAGGLUTININS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T06%3A46%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=IRONS,%20LAURENCE%20I&rft.date=1981-12-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA1114293A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true